Trulieve Cannabis Corp. logo TRLV - Trulieve Cannabis Corp.

Price: -- -- | PRICE TARGET: $15.00 DETAILS
HIGH: $15.00
LOW: $15.00
MEDIAN: $15.00
CONSENSUS: $15.00
UPSIDE: 80.07%
Annual Quarterly
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Revenue
Revenue 286.8 293.1 288.2 302.1
Cost of Revenue 116.7 118.0 118.3 119.2
Gross Profit 170.1 175.2 169.9 182.9
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 104.9 126.3 99.0 101.1
Other Expenses 29.7 29.4 29.5 29.4
Operating Expenses 134.6 155.7 128.5 130.5
Operating Income
Operating Income 35.4 19.4 41.4 52.4
Interest Expense 13.3 14.7 16.1 16.4
Interest Income 2.7 3.4 4.4 3.6
Profitability
EBITDA 82.3 61.3 88.8 98.4
EBIT 38.5 17.6 45.4 55.3
Income Before Tax 25.2 2.9 29.3 38.9
Income Tax Expense 21.9 47.9 53.0 54.7
Net Income 2.4 (42.9) (26.8) (13.8)
Per Share Data
EPS (Basic) 0.01 -0.22 -0.14 -0.07
EPS (Diluted) 0.01 -0.22 -0.14 -0.07
Shares Outstanding 192.5 191.7 191.2 191.2
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Current Assets
Cash & Cash Equivalents 352.9 255.5 449.2 392.6
Short-Term Investments 0 0 0 0
Net Receivables 22.1 20.2 19.4 21.2
Inventory 242.3 242.3 243.3 241.5
Other Current Assets 14.5 26.4 23.9 33.7
Total Current Assets 653.0 562.7 756.4 711.4
Non-Current Assets
Property, Plant & Equipment 852.0 838.7 865.6 881.1
Goodwill 483.9 483.9 483.9 483.9
Intangible Assets 780.8 798.4 815.3 832.4
Long-Term Investments 0 0 0 0
Other Non-Current Assets 12.4 12.4 20.3 13.0
Total Non-Current Assets 2,129.0 2,133.4 2,185.2 2,210.5
Total Assets 2,781.9 2,696.1 2,941.6 2,921.8
Current Liabilities
Account Payables 78.9 26.8 81.3 79.0
Short-Term Debt 4.1 4.1 3.7 3.7
Deferred Revenue 10.0 9.6 8.9 8.4
Other Current Liabilities 4.1 25.7 4.7 7.7
Total Current Liabilities 124.2 126.9 124.1 123.8
Non-Current Liabilities
Long-Term Debt 285.7 227.6 473.8 474.2
Deferred Tax Liabilities 169.8 178.0 181.9 186.6
Other Non-Current Liabilities 741.2 714.8 665.5 606.9
Total Non-Current Liabilities 1,508.5 1,426.1 1,631.2 1,588.5
Total Liabilities 1,632.6 1,553.1 1,755.3 1,712.4
Stockholders' Equity
Common Stock 0 0 0 0
Retained Earnings (909.7) (912.1) (869.2) (842.4)
Accumulated Other Comprehensive Income 0 0 0 0
Total Stockholders' Equity 1,167.8 1,161.2 1,203.8 1,225.0
Total Liabilities & Equity 2,781.9 2,696.1 2,941.6 2,921.8
Debt Metrics
Total Debt 628.7 563.6 813.1 823.7
Net Debt 275.8 308.1 363.9 431.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Operating Activities
Net Income 2.3 (43.6) (28.8) (16.1)
Depreciation & Amortization 43.7 43.7 43.4 43.1
Stock-Based Compensation 4.1 4.0 5.8 6.8
Change in Working Capital 10.9 51.6 54.8 46.1
Other Non-Cash Items 2.9 7.4 6.3 11.0
Operating Cash Flow 55.7 59.2 76.8 85.7
Investing Activities
Capital Expenditure (13.5) (7.0) (16.5) (16.2)
Acquisitions 0 0 0 0
Purchases of Investments 0 0 0 0
Sales/Maturities of Investments 0 0 (0.4) 0.4
Other Investing Activities 0.3 (2.5) (2.7) 2.9
Investing Cash Flow (13.2) (5.9) (15.4) (8.2)
Financing Activities
Net Debt Issuance 58.7 (385.9) (2.0) (3.6)
Stock Repurchased 0 0 0 0
Dividends Paid 0 0 0 0
Other Financing Activities (3.9) 130.5 (2.8) (2.2)
Financing Cash Flow 54.8 (255.4) (4.8) (5.8)
Cash Position
Net Change in Cash 97.3 (202.1) 56.6 71.6
Cash at Beginning 255.5 457.6 401.0 329.4
Cash at End 352.9 255.5 457.6 401.0
Free Cash Flow 42.2 52.2 60.3 69.5
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Income Statement
Revenue 286.8 293.1 288.2 302.1
Gross Profit 170.1 175.2 169.9 182.9
Operating Income 35.4 19.4 41.4 52.4
Net Income 2.4 (42.9) (26.8) (13.8)
EPS (Diluted) 0.01 -0.22 -0.14 -0.07
Balance Sheet
Cash & Equivalents 352.9 255.5 449.2 392.6
Total Assets 2,781.9 2,696.1 2,941.6 2,921.8
Total Debt 628.7 563.6 813.1 823.7
Stockholders' Equity 1,167.8 1,161.2 1,203.8 1,225.0
Cash Flow
Operating Cash Flow 55.7 59.2 76.8 85.7
Capital Expenditure (13.5) (7.0) (16.5) (16.2)
Free Cash Flow 42.2 52.2 60.3 69.5